Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 3061

1.

Change in Municipality-Level Health-Related Social Capital and Depressive Symptoms: Ecological and 5-Year Repeated Cross-Sectional Study from the JAGES.

Watanabe R, Kondo K, Saito T, Tsuji T, Hayashi T, Ikeda T, Takeda T.

Int J Environ Res Public Health. 2019 Jun 8;16(11). pii: E2038. doi: 10.3390/ijerph16112038.

2.

Acquired resistance mechanisms to afatinib in HER2-amplified gastric cancer cells.

Yoshioka T, Shien K, Takeda T, Takahashi Y, Kurihara E, Ogoshi Y, Namba K, Torigoe H, Sato H, Tomida S, Yamamoto H, Soh J, Fujiwara T, Toyooka S.

Cancer Sci. 2019 Jun 4. doi: 10.1111/cas.14089. [Epub ahead of print]

3.

Survival outcomes of appendiceal mucinous neoplasms by histological type and stage: Analysis of 266 cases in a multicenter collaborative retrospective clinical study.

Sueda T, Murata K, Takeda T, Kagawa Y, Hasegawa J, Komori T, Noura S, Ikeda K, Tsujie M, Ohue M, Ota H, Ikenaga M, Hata T, Matsuda C, Mizushima T, Yamamoto H, Sekimoto M, Nezu R, Mori M, Doki Y.

Ann Gastroenterol Surg. 2019 Feb 25;3(3):291-300. doi: 10.1002/ags3.12241. eCollection 2019 May.

4.

p.N345K mutation in TARDBP in a patient with familial amyotrophic lateral sclerosis: An autopsy case.

Takeda T, Iijima M, Shimizu Y, Yoshizawa H, Miyashiro M, Onizuka H, Yamamoto T, Nishiyama A, Suzuki N, Aoki M, Shibata N, Kitagawa K.

Neuropathology. 2019 May 24. doi: 10.1111/neup.12559. [Epub ahead of print]

PMID:
31124595
5.

The evaluation of gravitational recognition in patients with spinocerebellar degeneration using Listing's plane.

Takeda T, Ikeda T, Tsutsumi T.

Acta Otolaryngol. 2019 Jul;139(7):581-587. doi: 10.1080/00016489.2019.1607975. Epub 2019 May 20.

PMID:
31107126
6.

Jumping Crystal of a Hydrogen-Bonded Organic Framework Induced by the Collective Molecular Motion of a Twisted π System.

Takeda T, Ozawa M, Akutagawa T.

Angew Chem Int Ed Engl. 2019 May 20. doi: 10.1002/anie.201905075. [Epub ahead of print] Review.

PMID:
31106500
7.

Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users.

Asaoka D, Takeda T, Sasaki H, Shimada Y, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Komori H, Akazawa Y, Osada T, Hojo M, Nagahara A.

Biomed Rep. 2019 May;10(5):277-282. doi: 10.3892/br.2019.1206. Epub 2019 Apr 9.

8.

Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients.

Takamatsu K, Mizuno R, Tanaka N, Takeda T, Morita S, Matsumoto K, Kosaka T, Shinojima T, Kikuchi E, Asanuma H, Oyama M, Mikami S, Oya M.

Int J Clin Oncol. 2019 May 7. doi: 10.1007/s10147-019-01459-1. [Epub ahead of print]

PMID:
31065836
9.

The pretreatment circulating albumin-to-fibrinogen ratio in patients with non-small cell lung cancer: a simple, economical, and effective biomarker.

Hamanaka K, Miura K, Koyama T, Matsuoka S, Takeda T, Yamada K, Hyogotani A.

J Thorac Dis. 2019 Mar;11(Suppl 3):S241-S244. doi: 10.21037/jtd.2019.01.83. No abstract available.

10.

The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy.

Takamatsu K, Matsumoto K, Shojo K, Tanaka N, Takeda T, Morita S, Kosaka T, Mizuno R, Shinojima T, Kikuchi E, Asanuma H, Oya M.

Urol Oncol. 2019 Apr 6. pii: S1078-1439(19)30105-X. doi: 10.1016/j.urolonc.2019.03.012. [Epub ahead of print]

PMID:
30967332
11.

Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer.

Kurihara E, Shien K, Torigoe H, Takeda T, Takahashi Y, Ogoshi Y, Yoshioka T, Namba K, Sato H, Suzawa K, Yamamoto H, Soh J, Okazaki M, Shien T, Tomida S, Toyooka S.

Anticancer Res. 2019 Apr;39(4):1767-1775. doi: 10.21873/anticanres.13283.

PMID:
30952716
12.

Specific Features of Fibrotic Lung Fibroblasts Highly Sensitive to Fibrotic Processes Mediated via TGF-β-ERK5 Interaction.

Kadoya K, Togo S, Tulafu M, Namba Y, Iwai M, Watanabe J, Okabe T, Jin J, Kodama Y, Kitamura H, Ogura T, Kitamura N, Ikeo K, Takeda T, Kondo N, Takahashi K.

Cell Physiol Biochem. 2019;52(4):822-837. doi: 10.33594/000000057.

13.

Impact of Antimicrobial Prophylaxis for Severe Acute Pancreatitis on the Development of Invasive Candidiasis: A Large Retrospective Multicenter Cohort Study.

Horibe M, Sanui M, Sasaki M, Honda H, Ogura Y, Namiki S, Sawano H, Goto T, Ikeura T, Takeda T, Oda T, Yasuda H, Miyazaki D, Hirose K, Kitamura K, Chiba N, Ozaki T, Yamashita T, Koinuma T, Oshima T, Yamamoto T, Hirota M, Yamamoto S, Oe K, Ito T, Masuda Y, Saito N, Iwasaki E, Kanai T, Mayumi T.

Pancreas. 2019 Apr;48(4):537-543. doi: 10.1097/MPA.0000000000001269.

PMID:
30946245
14.

Selective Formation of a Mixed-Valence State from Linearly Bridged Oligo(aromatic diamines): Drastic Structural Change into a Folded Columnar Stack for Half-filled Polycations.

Nojo W, Ishigaki Y, Takeda T, Akutagawa T, Suzuki T.

Chemistry. 2019 Jun 7;25(32):7759-7765. doi: 10.1002/chem.201901272. Epub 2019 May 13.

PMID:
30942496
15.

In Silico Analysis of Relationship between Proteins from Plastid Genome of Red Alga Palmaria sp. (Japan) and Angiotensin I Converting Enzyme Inhibitory Peptides.

Kumagai Y, Miyabe Y, Takeda T, Adachi K, Yasui H, Kishimura H.

Mar Drugs. 2019 Mar 25;17(3). pii: E190. doi: 10.3390/md17030190.

16.

Successful Surgery of Right Common Iliac Artery Injury during Lumbar Discectomy with Endovascular Balloon Occlusion of the Aorta Performed by Cardiologists.

Takashima N, Lee J, Minamidate N, Fujita T, Yamaji M, Sakaguchi T, Takeda T, Mabuchi H.

Ann Vasc Dis. 2019 Mar 25;12(1):60-62. doi: 10.3400/avd.cr.18-00056.

17.

Psychometric properties of a sluggish cognitive tempo scale in Japanese adults with and without ADHD.

Takeda T, Burns GL, Jiang Y, Becker SP, McBurnett K.

Atten Defic Hyperact Disord. 2019 Mar 25. doi: 10.1007/s12402-019-00300-z. [Epub ahead of print]

PMID:
30911898
18.

Detection of a novel tick-borne flavivirus and its serological surveillance.

Shimoda H, Hayasaka D, Yoshii K, Yokoyama M, Suzuki K, Kodera Y, Takeda T, Mizuno J, Noguchi K, Yonemitsu K, Minami S, Kuwata R, Takano A, Maeda K.

Ticks Tick Borne Dis. 2019 Jun;10(4):742-748. doi: 10.1016/j.ttbdis.2019.03.006. Epub 2019 Mar 16.

PMID:
30902589
19.

Enhancement of Tissue Factor Expression in Monocyte-Derived Dendritic Cells by Pentraxin 3 and Its Modulation by C1 Esterase Inhibitor.

Kasuda S, Sakurai Y, Tatsumi K, Takeda T, Kudo R, Yuui K, Hatake K.

Int Arch Allergy Immunol. 2019;179(2):158-164. doi: 10.1159/000496744. Epub 2019 Mar 20.

PMID:
30893690
20.

Positive rates of anti-acari-borne disease antibodies of rural inhabitants in Japan.

Takeda T, Fujita H, Iwasaki M, Kasai M, Tatori N, Endo T, Kodera Y, Yamabata N.

J Vet Med Sci. 2019 May 31;81(5):758-763. doi: 10.1292/jvms.18-0572. Epub 2019 Mar 20.

21.

Learning Effect of Diagnosing Depth of Invasion Using Non-Extension Sign in Early Gastric Cancer.

Takeda T, So S, Sakurai T, Nakamura S, Yoshikawa I, Yada S, Itaba S, Yamagata H, Akiho H, Takatsu N, Wada Y, Ohtsu K, Nagahama T, Yao K.

Digestion. 2019 Mar 19:1-7. doi: 10.1159/000498845. [Epub ahead of print]

PMID:
30889600
22.

Post-intervention minimal stent area as a predictor of target lesion revascularization after everolimus-eluting stent implantation for in-stent restenosis: a single-center observational study.

Fujita T, Takeda T, Hano Y, Takashima N, Yamaji M, Sakaguchi T, Maeda K, Mabuchi H, Murakami T, Morimoto T, Kimura T.

Coron Artery Dis. 2019 Mar 13. doi: 10.1097/MCA.0000000000000731. [Epub ahead of print]

PMID:
30883432
23.

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation.

Yoshimura A, Yamada T, Okura N, Takeda T, Hirose K, Kubota Y, Shiotsu S, Hiranuma O, Chihara Y, Tamiya N, Kaneko Y, Uchino J, Takayama K.

Cancers (Basel). 2019 Mar 15;11(3). pii: E365. doi: 10.3390/cancers11030365.

24.

Multidisciplinary Lung Cancer Tumor Board Connecting Eight General Hospitals in Japan via a High-Security Communication Line.

Takeda T, Takeda S, Uryu K, Ichihashi Y, Harada H, Iwase A, Tamura Y, Hibino M, Horiuchi S, Kani H.

JCO Clin Cancer Inform. 2019 Mar;3:1-7. doi: 10.1200/CCI.18.00115.

25.

Effect of Extensive Ablation on Recurrence in Patients with Persistent Atrial Fibrillation Treated with Pulmonary Vein Isolation (EARNEST-PVI) trial: Design and rationale.

Dohi T, Nakatani D, Inoue K, Hikoso S, Oka T, Hayashi K, Masuda M, Furukawa Y, Kawasaki M, Egami Y, Kashiwase K, Hirata A, Watanabe T, Miyoshi M, Takeda T, Nakagawa A, Mizuno H, Minamiguchi H, Kitamura T, Suna S, Kojima T, Kida H, Bolrathanak O, Okuyama Y, Sakata Y; OCVC investigators.

J Cardiol. 2019 Aug;74(2):164-168. doi: 10.1016/j.jjcc.2019.01.010. Epub 2019 Mar 8.

PMID:
30853354
26.

Combination therapy with dacarbazine and statins improved the survival rate in mice with metastatic melanoma.

Tsubaki M, Takeda T, Obata N, Kawashima K, Tabata M, Imano M, Satou T, Nishida S.

J Cell Physiol. 2019 Mar 4. doi: 10.1002/jcp.28430. [Epub ahead of print]

PMID:
30834527
27.

A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia.

Komori H, Ueyama H, Nagahara A, Akazawa Y, Takeda T, Matsumoto K, Matsumoto K, Asaoka D, Hojo M, Yao T, Watanabe S.

J Int Med Res. 2019 Apr;47(4):1441-1452. doi: 10.1177/0300060519828514. Epub 2019 Feb 28.

28.

Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer.

Matsumoto K, Akita H, Narita K, Hashiguchi A, Takamatsu K, Takeda T, Kosaka T, Mizuno R, Kikuchi E, Oya M, Jinzaki M.

Prostate Cancer Prostatic Dis. 2019 Feb 27. doi: 10.1038/s41391-019-0136-3. [Epub ahead of print]

PMID:
30814680
29.

Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma.

Namba K, Tomida S, Matsubara T, Takahashi Y, Kurihara E, Ogoshi Y, Yoshioka T, Takeda T, Torigoe H, Sato H, Shien K, Yamamoto H, Soh J, Tsukuda K, Toyooka S.

BMC Cancer. 2019 Feb 26;19(1):175. doi: 10.1186/s12885-019-5374-1.

30.

Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR-mutated non-small cell lung cancer.

Yamada T, Hirai S, Katayama Y, Yoshimura A, Shiotsu S, Watanabe S, Kikuchi T, Hirose K, Kubota Y, Chihara Y, Harada T, Tanimura K, Takeda T, Tamiya N, Kaneko Y, Uchino J, Takayama K.

Cancer Med. 2019 Apr;8(4):1521-1529. doi: 10.1002/cam4.2037. Epub 2019 Feb 21.

31.

Endocytosis of CF in marginal cells of stria vascularis regulated by ROCK and MLCK signaling cascade, but not G-proteins.

Kakigi A, Okada T, Takeda T, Uehara N, Nibu KI.

Auris Nasus Larynx. 2019 Feb 7. pii: S0385-8146(18)30937-4. doi: 10.1016/j.anl.2019.01.007. [Epub ahead of print]

PMID:
30739815
32.

Remission of light chain proximal tubulopathy in IgG λ-type multiple myeloma by lenalidomide and dexamethasone therapy.

Kawamoto S, Hidaka Y, Kaneko Y, Misawa H, Nagahori K, Yoshino A, Okamura T, Ban S, Ueda Y, Takeda T.

CEN Case Rep. 2019 Feb 5. doi: 10.1007/s13730-019-00382-8. [Epub ahead of print]

33.

Sulfasalazine could modulate the CD44v9-xCT system and enhance cisplatin-induced cytotoxic effects in metastatic bladder cancer.

Ogihara K, Kikuchi E, Okazaki S, Hagiwara M, Takeda T, Matsumoto K, Kosaka T, Mikami S, Saya H, Oya M.

Cancer Sci. 2019 Apr;110(4):1431-1441. doi: 10.1111/cas.13960. Epub 2019 Mar 1.

34.

Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia.

Takeda T, Nakataki M, Ohta M, Hamatani S, Matsuura K, Yoshida R, Kameoka N, Tominaga T, Umehara H, Kinoshita M, Watanabe S, Numata S, Sumitani S, Ohmori T.

Neuropsychiatr Dis Treat. 2019 Jan 21;15:293-301. doi: 10.2147/NDT.S190381. eCollection 2019.

35.

Synthesis of the Non Reducing End Oligosaccharides of Glycosphingolipids from Ascaris suum.

Hada N, Umeda Y, Kumada H, Shimazaki Y, Yamano K, Schweizer F, Oshima N, Takeda T, Kiuchi F.

Chem Pharm Bull (Tokyo). 2019;67(2):143-154. doi: 10.1248/cpb.c18-00768.

36.

Impact of bowel movement condition on immune checkpoint inhibitor efficacy in patients with advanced non-small cell lung cancer.

Katayama Y, Yamada T, Tanimura K, Yoshimura A, Takeda T, Chihara Y, Tamiya N, Kaneko Y, Uchino J, Takayama K.

Thorac Cancer. 2019 Mar;10(3):526-532. doi: 10.1111/1759-7714.12969. Epub 2019 Jan 21.

37.

Ferroelectric Alkylamide-Substituted Helicene Derivative with Two-Dimensional Hydrogen-Bonding Lamellar Phase.

Anetai H, Takeda T, Hoshino N, Kobayashi H, Saito N, Shigeno M, Yamaguchi M, Akutagawa T.

J Am Chem Soc. 2019 Feb 13;141(6):2391-2397. doi: 10.1021/jacs.8b11222. Epub 2019 Jan 29.

PMID:
30646681
38.

Pioneer Factor NeuroD1 Rearranges Transcriptional and Epigenetic Profiles to Execute Microglia-Neuron Conversion.

Matsuda T, Irie T, Katsurabayashi S, Hayashi Y, Nagai T, Hamazaki N, Adefuin AMD, Miura F, Ito T, Kimura H, Shirahige K, Takeda T, Iwasaki K, Imamura T, Nakashima K.

Neuron. 2019 Feb 6;101(3):472-485.e7. doi: 10.1016/j.neuron.2018.12.010. Epub 2019 Jan 9.

PMID:
30638745
39.

Effects of Sitagliptin on Pancreatic Beta-Cells in Type 2 Diabetes With Sulfonylurea Treatment: A Prospective Randomized Study.

Sato A, Takei M, Hiramatsu K, Takeda T, Miyamoto T, Yamazaki M, Sato Y, Komatsu M.

J Clin Med Res. 2019 Jan;11(1):15-20. doi: 10.14740/jocmr3632. Epub 2018 Dec 3.

40.

Slower Reorientation of Trunk for Reactive Turning while Walking in Hemiparesis Stroke Patients.

Nakamura T, Higuchi T, Kikumoto T, Takeda T, Tashiro H, Hoshi F.

J Mot Behav. 2019 Jan 2:1-7. doi: 10.1080/00222895.2018.1547894. [Epub ahead of print]

PMID:
30600784
41.

[Emergent Re-do Mitral Valve Replacement for Prosthetic Valve Endocarditis with Increasing Obstruction of Mitral Valve].

Paku M, Takeda T, Kohno S.

Kyobu Geka. 2018 Dec;71(13):1084-1087. Japanese.

PMID:
30587747
42.
43.

Phosphorylation of cortactin by cyclin-dependent kinase 5 modulates actin bundling by the dynamin 1-cortactin ring-like complex and formation of filopodia and lamellipodia in NG108-15 glioma-derived cells.

Abe T, La TM, Miyagaki Y, Oya E, Wei FY, Sumida K, Fujise K, Takeda T, Tomizawa K, Takei K, Yamada H.

Int J Oncol. 2019 Feb;54(2):550-558. doi: 10.3892/ijo.2018.4663. Epub 2018 Dec 11.

44.

Management of malignant carinal involvement using 'side-by-side' method of bilateral self-expandable metallic stents.

Takeda T, Itano H, Wakasa R, Saitoh M, Takeda S.

Respirol Case Rep. 2018 Dec 10;7(2):e00396. doi: 10.1002/rcr2.396. eCollection 2019 Feb.

45.

The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations.

Yoshimura A, Yamada T, Okura N, Takeda T, Furutani W, Kubota Y, Shiotsu S, Hiranuma O, Nishioka N, Chihara Y, Tamiya N, Kaneko Y, Uchino J, Takayama K.

BMC Cancer. 2018 Dec 11;18(1):1241. doi: 10.1186/s12885-018-5153-4.

46.

Is transperitoneal laparoscopic radical nephrectomy suitable for patients with a history of abdominal surgery?

Yanai Y, Takeda T, Miyajima A, Matsumoto K, Hagiwara M, Mizuno R, Kikuchi E, Asanuma H, Oya M.

Asian J Endosc Surg. 2018 Dec 2. doi: 10.1111/ases.12673. [Epub ahead of print]

PMID:
30506839
47.

Comparison of early and delayed EUS-guided drainage of pancreatic fluid collection.

Chantarojanasiri T, Yamamoto N, Nakai Y, Saito T, Saito K, Hakuta R, Ishigaki K, Takeda T, Uchino R, Takahara N, Mizuno S, Kogure H, Matsubara S, Tada M, Isayama H, Koike K.

Endosc Int Open. 2018 Dec;6(12):E1398-E1405. doi: 10.1055/a-0751-2698. Epub 2018 Nov 23.

48.

Warburg effect in Gynecologic cancers.

Kobayashi Y, Banno K, Kunitomi H, Takahashi T, Takeda T, Nakamura K, Tsuji K, Tominaga E, Aoki D.

J Obstet Gynaecol Res. 2019 Mar;45(3):542-548. doi: 10.1111/jog.13867. Epub 2018 Dec 3. Review.

PMID:
30511455
49.

Fluid sequestration is a useful parameter in the early identification of severe disease of acute pancreatitis.

Takeda T, Nakai Y, Mizuno S, Suzuki T, Sato T, Hakuta R, Ishigaki K, Saito K, Saito T, Watanabe T, Takahara N, Mouri D, Kogure H, Ito Y, Hirano K, Tada M, Isayama H, Koike K.

J Gastroenterol. 2019 Apr;54(4):359-366. doi: 10.1007/s00535-018-1531-6. Epub 2018 Nov 26.

PMID:
30478723
50.

Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Cells.

Namba K, Shien K, Takahashi Y, Torigoe H, Sato H, Yoshioka T, Takeda T, Kurihara E, Ogoshi Y, Yamamoto H, Soh J, Tomida S, Toyooka S.

Mol Cancer Res. 2019 Feb;17(2):499-507. doi: 10.1158/1541-7786.MCR-18-0628. Epub 2018 Nov 21.

PMID:
30463991

Supplemental Content

Loading ...
Support Center